![Dave Frantze](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dave Frantze
Direktor/Vorstandsmitglied bei
BioNOVUS Innovations LLC
Profil
Dave Frantze is currently a Board of Director at BioNOVUS Innovations LLC and a Partner at Stinson LLP since 1987.
He completed his undergraduate degree in 1976 from Avila University and his undergraduate degree in 1981 from the University of Missouri-Kansas City School of Law.
Aktive Positionen von Dave Frantze
| Unternehmen | Position | Beginn |
|---|---|---|
BioNOVUS Innovations LLC
 BioNOVUS Innovations LLC Investment ManagersFinance BioNOVUS Innovations invests in both public and private companies located in the United States. The firm targets companies operating in the field of the healthcare sector. It provides financing for early stage capital requirements. | Direktor/Vorstandsmitglied | - |
Stinson LLP
 Stinson LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Private Equity Investor | 01.01.1987 |
Ausbildung von Dave Frantze
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
48
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Stinson LLP
Stinson LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Avila University
 Avila University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Missouri-Kansas City School of Law
 University of Missouri-Kansas City School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioNOVUS Innovations LLC
BioNOVUS Innovations LLC Investment ManagersFinance BioNOVUS Innovations invests in both public and private companies located in the United States. The firm targets companies operating in the field of the healthcare sector. It provides financing for early stage capital requirements. | Finance |
